Order Article Reprints

Furqan M, Elliott RJR, Nagle PWK, Dawson JC, Masalmeh R, Garcia VA, Munro AF, Drake C, Morrison GM, Pollard SM, et al. Drug Combinations Targeting FAK and MEK Overcomes Tumor Heterogeneity in Glioblastoma. Pharmaceutics. 2025; 17(5):549. https://doi.org/10.3390/pharmaceutics17050549

Furqan, Muhammad, Richard J. R. Elliott, Peter W. K. Nagle, John C. Dawson, Roza Masalmeh, Virginia Alvarez Garcia, Alison F. Munro, Camilla Drake, Gillian M. Morrison, Steven M. Pollard, and et al. 2025. "Drug Combinations Targeting FAK and MEK Overcomes Tumor Heterogeneity in Glioblastoma" Pharmaceutics 17, no. 5: 549. https://doi.org/10.3390/pharmaceutics17050549

Furqan, M., Elliott, R. J. R., Nagle, P. W. K., Dawson, J. C., Masalmeh, R., Garcia, V. A., Munro, A. F., Drake, C., Morrison, G. M., Pollard, S. M., Ebner, D., Brunton, V. G., Frame, M. C., & Carragher, N. O. (2025). Drug Combinations Targeting FAK and MEK Overcomes Tumor Heterogeneity in Glioblastoma. Pharmaceutics, 17(5), 549. https://doi.org/10.3390/pharmaceutics17050549